US8604046, 105

ID: ALA3680112

Chembl Id: CHEMBL3680112

PubChem CID: 46235612

Max Phase: Preclinical

Molecular Formula: C29H37F3N4O2

Molecular Weight: 530.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1CCCN1[C@H]1CCN(c2ccc(N3CCC4(CCN(Cc5ccco5)CC4)C3=O)c(C(F)(F)F)c2)C1

Standard InChI:  InChI=1S/C29H37F3N4O2/c1-21-4-2-12-35(21)23-8-13-34(19-23)22-6-7-26(25(18-22)29(30,31)32)36-16-11-28(27(36)37)9-14-33(15-10-28)20-24-5-3-17-38-24/h3,5-7,17-18,21,23H,2,4,8-16,19-20H2,1H3/t21-,23-/m0/s1

Standard InChI Key:  SAKZWHDDNTUCCS-GMAHTHKFSA-N

Associated Targets(non-human)

HRH3 Histamine receptor H3 (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 530.64Molecular Weight (Monoisotopic): 530.2869AlogP: 5.38#Rotatable Bonds: 5
Polar Surface Area: 43.17Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.68CX LogP: 4.20CX LogD: 1.08
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.52Np Likeness Score: -1.12

References

1.  (2013)  Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof, 

Source

Source(1):